Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $1.03
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Jun 9, 25 |
Daily · Wilder smoothing
| Lake Street |
| maintain |
| Buy |
| Buy |
| Apr 15, 24 | Loop Capital | maintain | Buy | Buy |
| Mar 15, 24 | Roth MKM | maintain | Buy | Buy |
| Nov 20, 18 | Loop Capital | upgrade | Hold | Buy |
| Jan 23, 17 | Roth Capital | upgrade | Neutral | Buy |
| Nov 28, 16 | Piper Sandler | upgrade | Underweight | Neutral |
| Nov 28, 16 | PiperJaffray | upgrade | Underweight | Neutral |
| Aug 3, 16 | SunTrust Robinson Humphrey | upgrade | Neutral | Buy |
| Jul 13, 16 | BB&T Capital | downgrade | Buy | Hold |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 18.40 | Oscillator | Buy |
| Stochastic %K (14, 3, 3) | 4.72 | Oscillator | Buy |
| Williams %R (14) | -96.15 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.27 (Hist -0.03) | Oscillator | Strong Sell |
| Average Directional Index (14) | 63.71 (+DI 3.0 / -DI 40.7) | Trend | Strong Sell |
| EMA 20 | 1.39 | MA | Strong Sell |
| SMA 20 | 1.43 | MA | Strong Sell |
| EMA 50 | 1.79 | MA | Strong Sell |
| SMA 50 | 1.89 | MA | Strong Sell |
| SMA 200 | 2.94 | MA | Strong Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | AVD | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -0.5x | 17.4x · sector 16.6x | Discount |
| Forward P/E (FY26E) | 2.7x | EPS est. 0.38 | Discount |
| Price / Book | 0.2x | 1.0x | Discount |
| Price / Sales | 0.1x | 0.6x | Discount |
| EV / EBITDA | -24.6x | -4.6x | Elevated |
| Return on equity | -27.8% | — | Weak |
| Gross margin | 29.4% | 30.4% | In line |
| Debt / Equity | 1.57 | 0.51 | Levered |
| Piotroski / Altman Z | 3/9 | Z 1.47 | Distress |
Discounted cash flow model
Stock news · updated daily
IRVINE, CA / ACCESS Newswire / October 1, 2026 / American Vanguard Corporation (NYSE:AVD), a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today announced a transition in the Chief Financial Officer (CFO) role. Matt Horwath will join American Vanguard on October 1, 2026 as Chief Financial Officer, succeeding David Johnson as part of a planned leadership transition.
IRVINE, CA / ACCESS Newswire / September 29, 2026 / American Vanguard Corporation (NYSE:AVD) today announced that its principal operating subsidiary, AMVAC Chemical Corporation (AMVAC), has entered into agreements with Syngenta Crop Protection, LLC and Syngenta Crop Protection AG to acquire the U.S. rights to four established crop-protection brands: Caparol®, Evik®, Prime+® and Agri-Flex®. "The addition of these well-established brands to the AMVAC portfolio expands and strengthens our offerings in core crops while providing American farmers solutions for their specific field challenges," said Dak.
IRVINE, CA / ACCESS Newswire / August 11, 2026 / American Vanguard Corporation (NYSE:AVD) today announced Mark Helt joined the company as U.S. Crop President. Mark brings more than 25 years of commercial leadership experience across the North American crop protection, seed, and specialty markets.
American Vanguard NYSE: AVD reported lower second-quarter sales amid challenging agricultural market conditions, while management said U.S. specialty growth, cost actions and product-development investments supported its full-year outlook.
American Vanguard Corporation (AVD) Q2 2026 Earnings Call Transcript
IRVINE, CA / ACCESS Newswire / August 10, 2026 / American Vanguard Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the second quarter and six-months ended June 30, 2026.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | 0.09 | -0.34 | Miss -477.8% | $116.8M |
| May 6, 2026 | -0.06 | -0.14 | Miss -133.3% | $123.6M |
| Mar 16, 2026 | 0.28 | 0.97 | Beat 246.4% | $150.7M |
| Nov 10, 2025 | -0.08 | -0.43 | Miss -437.5% | $119.3M |
| Jul 31, 2025 | -0.11 | -0.03 | Beat 72.7% | $129.3M |
| Jun 5, 2025 | -0.07 | -0.30 | Miss -328.6% | $115.8M |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Aug 18, 26 | Rosenbloom Keith M | director | S-Sale | 556,580 @ $2.20 | $1.22M |
| Aug 17, 26 | Macicek Steven D | director | P-Purchase | 19,000 @ $2.09 | $39.71K |
| Jul 10, 26 | Kaye Douglas | officer: CHIEF EXECUTIVE OFFICER | J-Other | 6,527 @ $2.36 | $15.40K |
| Jun 4, 26 | Rosenbloom Keith M | director | A-Award | 31,872 | — |
| Jun 4, 26 | Johnson David` T. | officer: See Remarks | A-Award | 20,000 @ $2.51 | $50.20K |
| Jun 4, 26 | Kaye Douglas | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | 50,000 @ $2.51 | $125.5K |
| Jun 3, 26 | Kaye Douglas | officer: CHIEF EXECUTIVE OFFICER | P-Purchase | 5,000 @ $2.50 | $12.50K |
| Jun 4, 26 | Mcdougal Rubin J | director | A-Award | 31,872 | — |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
| 8-K | Aug 11, 2026 | 2026-08-11 16:08:23 | View |
| 10-Q | Aug 10, 2026 | 2026-08-10 16:30:43 | View |
| SC 13G/A | Jul 27, 2026 | 2026-07-27 16:25:24 | View |
| 4 | Jul 14, 2026 | 2026-07-14 19:44:09 | View |
| 4 | Jun 9, 2026 | 2026-06-09 20:24:44 | View |
| 4 | Jun 8, 2026 | 2026-06-08 18:06:30 | View |
Proxy statement (DEF 14A) disclosures